FCA1-0798

A new drug treatment has been developed for Crohn’s disease. The pharmaceutical company behind this, is planning to conduct a trial and is looking for hiring around 200 individuals that are suffering from Crohn’s disease. The aim would be to determine if there is any decline in the disease activity in response to the drug and compare it with a placebo. What phase is the trial in?